CRNX CRINETICS PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Management Change Crinetics Pharmaceuticals appointed Isabel Kalofonos as Chief Commercial Officer effective December 16, 2024, with a $500,000 salary and a 40% bonus target, to lead commercial strategies for their upcoming product launch.Get access to all SEC 8-K filings of the CRINETICS PHARMACEUTICALS INC